Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,577,393
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
8,576,486
-
Shares change
-
+3,282,066
-
Total reported value, excl. options
-
$45,797,587
-
Value change
-
+$17,940,647
-
Put/Call ratio
-
4.9%
-
Number of buys
-
43
-
Number of sells
-
16
-
Price
-
$5.34
Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q1 2024
As of 31 Mar 2024 Cardiff Oncology, Inc. - Common Stock (CRDF) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,576,486 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MAI Capital Management, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, GOLDMAN SACHS GROUP INC, Assenagon Asset Management S.A., and BIT Capital GmbH.
This table shows 74 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.